mm

Carl Foster

Carl Foster๋Š” Standigm์˜ ์ตœ๊ณ  ๋น„์ฆˆ๋‹ˆ์Šค ์ฑ…์ž„์ž๋กœ์„œ, ์›Œํฌํ”Œ๋กœ์šฐ ์ธ๊ณต์ง€๋Šฅ(AI) ์•ฝ๋ฌผ ๋ฐœ๊ฒฌ ํšŒ์‚ฌ์ž…๋‹ˆ๋‹ค. ๋ฐ”์ด์˜คํ…Œํฌ ๋ฐ ์ œ์•ฝ ์—…๊ณ„์˜ ๋ฒ ํ…Œ๋ž‘ ์ž„์›์ธ ํฌ์Šคํ„ฐ๋Š” AI ์•ฝ๋ฌผ ๋ฐœ๊ฒฌ์„ ์œ„ํ•œ ์ „๋žต์  ์ œํœด๋ฅผ ํ™•๋Œ€ํ•˜์—ฌ Standigm์ด ์„ฑ์žฅ๊ณผ ๊ตญ์ œ์  ์˜ํ–ฅ๋ ฅ์„ ์ฆ๊ฐ€ํ•˜๋„๋ก ๋„์™€์ค๋‹ˆ๋‹ค. ๊ทธ๋Š” ์œ ์ „์ฒดํ•™, ๋‹จ๋ฐฑ์ฒดํ•™ ๋ฐ ํ•ญ์ฒด๋ฅผ ํฌํ•จํ•œ ๋‹ค์–‘ํ•œ ๋ถ„์•ผ์—์„œ ์•ฝ๋ฌผ ๋ฐ ํ”Œ๋žซํผ ๊ธฐ์ˆ  ํšŒ์‚ฌ์—์„œ 30๋…„ ์ด์ƒ์˜ ๊ฒฝํ—˜์„ ๊ฐ€์ง€๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ๊ทธ์˜ ๊ฒฝ๋ ฅ ๋™์•ˆ - Merck and Co., Cempra Pharmaceuticals, Jurilab, Nanogen, King Pharmaceuticals, Oxford GlycoSciences, Praecis Pharmaceuticals, Intracel BV, Ferghana Partners ๋ฐ ํ˜„์žฌ Standigm์—์„œ - ํฌ์Šคํ„ฐ๋Š” ๋น„์ฆˆ๋‹ˆ์Šค ๊ณ„ํš, ์ „๋žต์  ๊ด€๊ณ„ ๊ตฌ์ถ• ๋ฐ ์žฌ๋ฌด ๋ชจ๋ธ๋ง์— ๊ฐ•ํ•œ ์‹ค์ ์„ ๊ตฌ์ถ•ํ–ˆ์Šต๋‹ˆ๋‹ค. Carl Foster๋Š” ์บ”์‚ฌ์Šค ๋Œ€ํ•™๊ต์—์„œ ๋งˆ์ผ€ํŒ… ๋ฐ ์ƒํ™”ํ•™ ์„์‚ฌ ํ•™์œ„๋ฅผ ๊ฐ€์ง€๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.